Form D · Other Health Care

CorneaGen Inc.

Seattle, WA · CIK 0001687524

Offering snapshot reported May 15, 2018 · SEC filing

Reported sold
$2M
Offering amount: $2M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 5, 2018
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 15, 2018Initial$2,000,000No comparison1SEC filing
Apr 19, 2018Initial$5,000,000No comparison1SEC filing
Oct 18, 2016Initial$10,000,000No comparison1SEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-312449

Source: Form D, filed May 15, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Gretchen Coker Executive
Bernie Iliakis Executive
Richard Lindstrom Director
William Link Director
Tim Mclaughlin Executive
Howard Mendelsohn Executive
Monty Montoya Director, Executive
Kush Parikh Director
Bob Stevens Executive
Melody Summers Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
1200 6 Th Avenue, Suite 300
Seattle, WA, 98101